Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis–Eligible Population
The Journal of Infectious Diseases · 15.04.2025 · 231 (4) · e708-e712
DOI: 10.1093/infdis/jiae634 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 24.12.2024. Verfasst von Rachel Mittelstaedt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital. Hauptthemen laut MEDLINE: Doxycycline, Anti-Bacterial Agents, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, CDC HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Among doxycycline postexposure prophylaxis (doxy-PEP)–eligible men, Staphylococcus aureus tetracycline nonsusceptibility is more prevalent than in the overall population and is associated with resistance to trimethoprim-sulfamethoxazole and clindamycin. Doxy-PEP may select for multidrug-resistant S aureus, underscoring the importance of surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital.
- Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health.
- Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute.
- Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts.
ORCID-Profile: Rachel Mittelstaedt, Sanjat Kanjilal, Yonatan H Grad
Förderung
- NIAID NIH HHS
- CDC HHS
- National Institute of Allergy and Infectious Diseases
- Centers for Disease Control and Prevention
Zitieren
APA
Mittelstaedt, R., Kanjilal, S., Helekal, D., Robbins, G. K., & Grad, Y. H. (2025). Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis–Eligible Population. The Journal of Infectious Diseases, 231(4), e708-e712. https://doi.org/10.1093/infdis/jiae634
Vancouver
Mittelstaedt R, Kanjilal S, Helekal D, Robbins GK, Grad YH. Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis–Eligible Population. The Journal of Infectious Diseases. 2025;231(4):e708-e712. doi:10.1093/infdis/jiae634
BibTeX
@article{Mittelstaedt2025,
author = {Mittelstaedt, Rachel and Kanjilal, Sanjat and Helekal, David and Robbins, Gregory K and Grad, Yonatan H},
title = {Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis–Eligible Population},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {231},
number = {4},
pages = {e708--e712},
doi = {10.1093/infdis/jiae634}
}
EUVIMED